EarningsQ2 2024 Earnings Report

Jazz Pharmaceuticals (JAZZN) Q2 2024 Earnings Report

0 Followers

MX:JAZZN Q2 2024 EPS Results

Actual EPS$95.79

Consensus EPS$88.96

Beat/MissBeat by +$6.83

One Year Ago EPS$81.51

Actual Revenue$18.50B

Expected Revenue$18.25B

Beat/MissBeat by +$250.46M

YoY Revenue Growth+6.95%

QuarterQ2 2024

Date07/31/2024

TimeAfter Close

Conference CallWednesday, July 31, 2024

MX:JAZZN Upcoming Earnings

Jazz Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:JAZZN Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	116.28 / -	146.937	―
Aug 03, 2026	2026 (Q2)	111.60 / 103.20	-149.105	169.21% (+252.30)
May 05, 2026	2026 (Q1)	83.88 / 114.59	30.363	277.38% (+84.22)
Feb 24, 2026	2025 (Q4)	117.80 / 120.01	119.284	0.61% (+0.72)
Nov 05, 2025	2025 (Q3)	107.46 / 146.94	119.465	23.00% (+27.47)
Aug 05, 2025	2025 (Q2)	-137.47 / -149.11	95.789	-255.66% (-244.89)
May 06, 2025	2025 (Q1)	84.19 / 30.36	48.437	-37.31% (-18.07)
Feb 25, 2025	2024 (Q4)	105.95 / 119.28	90.728	31.47% (+28.56)
Nov 06, 2024	2024 (Q3)	99.37 / 119.47	87.475	36.57% (+31.99)
Jul 31, 2024	2024 (Q2)	88.96 / 95.79	81.511	17.52% (+14.28)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed